参考文献 References
[1] Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas[J]. Gastroenterology,2009,136(4):1134-1144.
[2] Shabanzadeh DM. Incidence of gallstone disease and complications[J]. Curr Opin Gastroenterol, 2018, 34(2): 81-89.
[3] Alemi F, Seiser N, Ayloo S. Gallstone Disease: Cholecystitis, Mirizzi Syndrome, Bouveret Syndrome, Gallstone Ileus[J]. Surg Clin North Am,2019, 99(2): 231-244.
[4] Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 199 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal[J]. J Gastrointest Oncol, 2012, 3(2): 105-119.
[5] Tsen A, Barbara M, Rosenkranz L. Dilemma of elevated CA 199 in biliary pathology[J]. Pancreatology, 2018, 18(8): 862-867.
[6] Qin XL, Wang ZR, Shi JS, et al. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA[J]. World J Gastroenterol,2004,10(3):427-432.
[7] Kim MS, Jeon TJ, Park JY, et al. Clinical Interpretation of Elevated CA 199 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary Disease [J]. Korean J Gastroenterol,2017,70(2):96-102.
[8] Cui L, Lv N, Li B, et al. Serum CA 199 Level is Correlated to the Clinical Characteristics and Chronic Complications of Patients Newly Diagnosed with Type 2 Diabetes Mellitus[J]. Exp Clin Endocrinol Diabetes,2019.
[9] Singh S, Tang SJ, Sreenarasimhaiah J, et al. The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma[J]. Dig Dis Sci,2011, 56(8): 2491-2496.
[10] Howaizi M, Abboura M, Krespine C, et al. A new cause for CA19.9 elevation: heavy tea consumption[J]. Gut, 2003, 52(6):913-914.
[11] Shin JY, Yoo SJ, Park BM, et al. Extremely increased serum carbohydrate antigen 19-9 levels caused by new or resistant infections to previous antibiotics in chronic lung diseases[J]. Tuberc Respir Dis (Seoul), 2013, 75(3): 125-127.
[12] Onishi T, Franco OE, Shibahara T, et al. Papillary adenocarcinoma of the renal pelvis and ureter producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125[J]. Int J Urol, 2005, 12(2): 214-216.
[13] Robertson AG, Davidson BR. Mirizzi syndrome complicating an anomalous biliary tract: a novel cause of a hugely elevated CA19-9[J]. Eur J Gastroenterol Hepatol, 2007, 19(2):167-169.
[14] Morris-Stiff G, Teli M, Jardine N, et al. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease[J]. Hepatobiliary Pancreat Dis Int, 2009, 8(6):620-626.
[15] Teng D, Wu K, Sun Y, et al. Significant increased CA 199 levels in acute pancreatitis patients predicts the presence of pancreatic cancer[J]. Oncotarget, 2018, 9(16): 12745-12753.
[16] Mei Y, Chen L, Peng CJ, et al. Diagnostic value of elevated serum carbohydrate antigen 199 level in acute cholangitis secondary to choledocholithiasis[J]. World J Clin Cases,2018,6(11):441-446.
[17] 张玉富，张 磊，李晓勇.血清 CA19 -9 与前白蛋白对胆总管结石梗阻性黄疸 患者发生急性胆管炎的预测价值. 2020,18(2):47-51.
[18] 安孟增，杨景红，董祖海. CA 199、hsCRP、TSGF在梗阻性黄疸鉴别诊断中的意义. [J]．右江民族医学，2013（4）：440-443
[19] Gamboa AC, Maithel SK. The Landmark Series: Gallbladder Cancer[J]. Annals of surgical oncology, 2020, 27(8): 2846-2858.
[20] 杨平湖.血清CEA、CA199水平在胆道恶性肿瘤早期诊断中的价值.中外医学研究. 2016,14（35）：8-10.